Kraig Labs Installing New Silk Processing Equipment to Speed up Delivery Times for Spider Silk

ANN ARBOR, Mich., – April 17, 2017 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that it is expanding domestic recombinant spider silk production capacity with the purchase and installation of a new commercial scale cocoon processing machine.  This new equipment arrived in early April, is being installed now, and is expected to be fully operational before the end of the month. 

This machine replaces a much smaller cocoon processing machine the Company has been using to produce materials under a contract with the US Army.  The increased capacity and efficiency this new equipment offers will free up production staff and lower overall costs. 

Over the next month the Company plans to supply the Army with sample single filament Dragon Silk fibers for independent testing and to have the first batch of finished Dragon Silk thread ready for knitting into Ballistic shootpacks.  The Company anticipates completing the additional silk necessary for producing the woven shootpacks for the US Army in the third quarter.  This newly installed equipment is expected to play an important role in meeting this new timeline. 

“In many cases, up until now, we’ve been working with research scale equipment as we transitioned out of the laboratory,” said COO Jon Rice.  “We had originally hoped to have completed all silk production for the first Army contact by now.  That timeline, in consultation with our customer, has been extended due to challenges that a third party vendor had in scheduling and processing as well as the throughput limitations of our production facility in its first month of operations.  This new equipment can process more cocoons in one hour than we currently process in a month and it is expected to play an important role in meeting the new timeline.  This new commercial scale machine is expected to sustain our domestic production capacity through 2019 and reduce labor costs significantly.”

In addition to its planned expansion of domestic production, the Company, as earlier announced, is working to establish a significant overseas production operation.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

The issuance of the Investment Certificate is a major step toward high tech silk production in Vietnam

ANN ARBOR, Mich., – March 27, 2017 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that it has just been awarded an Investment Certificate for the production of high technology silk in Vietnam’s Quang Nam province.

The Investment Certificate was issued to the Company during the March 26, 2017 Quang Nam Investment Conference, which was attended by Vietnam’s Prime Minister and numerous high level central government officials, including the ministers of all relevant governmental departments, as well as high level officials from Quang Nam province, including the Chairman and key provincial officials. Representing Kraig Labs at the meeting were the Company’s CEO and Founder, Kim Thompson, and COO, Jon Rice.

“It was an honor to receive this award on stage from the Chairman in front of the Prime Minister,” said Thompson. “This is a huge step forward in our plans to expand production on a large scale. We look forward to the opportunity to revitalize silk production, using high technology, in an area of the world with a strong history of quality silks and textiles.”
This Investment Certificate award was the necessary and final step before the Company seeks central government approval for the expansion of Kraig Labs’ business. The Company’s efforts to secure that final approval are well underway.

“I would like to personally thank the Chairman and his staff for working so closely with us to finalize the Investment Certificate,” stated Rice. “While this is a momentous occasion for Kraig Biocraft Laboratories and our shareholders, it is also a turning point in the commercialization of advanced fibers.”

 
The Investment Conference is receiving significant media coverage in Vietnam, including several English language media outlets.

 
To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

ANN ARBOR, Mich., – March 17, 2017 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that the Company’s management just completed a site survey trip in Quang Nam province, Vietnam, with Vietnamese officials. 

Company leadership worked with local officials to identify potential locations for the Company’s silk production operations.  Properties identified include a Greenfield site and existing facilities that should meet both short term and long term requirements for space and production.  The Company is now working with Vietnamese officials to pursue approvals for investment and for the introduction of our hybrid silkworm.

“After touring the province and reviewing numerous potential sites, I believe we’ve found excellent locations to begin production in Vietnam,” said COO Jon Rice.  “We are still working to secure necessary approvals and no final decisions have been made. However, the region’s existing infrastructure and expertise are cause to believe that we should be able to follow the same operation ramp up as our Indiana facility.  We would like to, again, thank our Vietnamese host for their hospitality and look forward to future meetings and discussions.” 

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -March 3, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it has completed the planting of the first 2,000 mulberry trees at its Texas location.  This facility and these trees will be used to supply the Company’s US recombinant spider silk operations with fresh mulberry leaves.  The Company expects to begin harvesting these leaves in the 3^rd or 4^th quarter of this year. 

“We’ve invested a tremendous amount of effort over the last thirty days preparing the new Texas facility and planting these first 2,000 trees,” said COO Jon Rice.  “Those long days and a handful of fire ant bites have rewarded us, with what we expect, will be the capacity to support all of our US silk production without the need of expensive artificial diet.  We’re looking forward to our first harvest this fall.”

The Company is now in the process of assessing its needs for additional mulberry trees and will make a decision regarding additional plantings later this year.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs signs long term lease and prepares to plant 2,000 mulberry trees

ANN ARBOR, Mich., -January 24, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it had secured a long term property lease in Texas for the Company’s domestic mulberry production. Over the next 60 days the Company will complete the first phase of expansion by preparing the land and planting 2,000 mulberry trees. These trees will provide the Company with the continuous supply of fresh mulberry leaves needed to produce its record setting Dragon Silk^TM. The Company expects to see an improvement in materials performance and a reduction in production costs by as much as 30% through the use of locally sourced mulberry.

“Signing this lease and opening this new facility brings with it a new era for Kraig Labs and silk production in the US,” said COO Jon Rice. “Establishing domestic mulberry production has long been a key piece of our growth plan, today we are pleased to be able share the success of our efforts in bringing that vision into reality. Over the coming months we will complete the planting of the first 2,000 trees and prepare the facility for the next phase of expansion.”

This property offers the Company significant capacity for growth with room for tens of thousands of more trees.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – January 12, 2017 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that the Company’s management just completed a series of successful meetings with government officials in Vietnam designed to outline a collaborative path to large scale production of the Company’s high performance silk technologies.  Following the meeting with provincial leadership, Company management toured mulberry production, silkworm rearing, and textile weaving facilities in the province of Quang Nam to better assess the region’s capacity. 

“We were very impressed with what we saw in Quang Nam, its people, history, and capacity makes it a great location for our advanced silk production,” said COO Jon Rice.

“We would, again, like to thank the Chairman, Vice Chairman and numerous other leaders of the province for their support and enthusiasm in exploring the opportunity to bring our technology to Quang Nam province,” added Company founder and CEO, Kim Thompson. 

This meeting was also recently reported by officials in Quang Nam province, Vietnam.  http://ipaquangnam.gov.vn/eng/tin-tuc-chi-tiet/lanh-dao-ubnd-tinh-tiep-va-lam-viec-voi-lanh-dao-cong-ty-kraig-biocraft-laboratories-hoa-ky.html

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -December 6, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, was featured in the broadcast television show “Nature Knows Best” aired on November 19th. “Nature Knows Best” is a nationally syndicated STEM series exploring how scientists and engineers mimic nature to create some of the world’s most amazing materials. The segment from episode 11 of this series featuring Kraig Labs can be found on the Company’s YouTube channel at:

https://youtu.be/p68KPyAsiug or;

https://www.kraiglabs.com/videos/

“Nature Knows Best” is produced by Steve Rotfeld Productions and airs on Fox. The first 9 full episodes of “Natures Knows Best” are currently available for streaming on Amazon, Ruko, or Hulu.

“I want to personally thank Danni Washington and the entire ‘Nature Knows Best’ crew for doing such an incredible job of featuring our spider silk technology,” said COO Jon Rice. “We are always looking for ways to share our incredible technology and materials with new audiences. To be included in such a strong episode of this innovative science program, just as we’re preparing to ship out or first production order of Dragon silk cocoons from our Indiana factory, is very exciting.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories Promising New Line of Silkworm Transgenics Shows Incredible Results

ANN ARBOR, Mich., -October 31, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it has created a new line of genetically engineered silkworms that rival the Company’s Dragon Silk^TM  for the title as world’s strongest and most flexible recombinant spider silk.   Based on early testing results, this new line has a high probability of delivering performance exceeding that of the record setting Dragon Silk line announced in 2015.  Over the next several months the Company will conduct a thorough evaluation and performance comparison between these two incredible materials.

“This brand new transgenic is the result of more than a year of dedicated development and thousands of individual microinjections,” said COO Jon Rice.  “We used a completely different approach in designing this new line to solving the challenge of commercially scalable spider silk.  This different approach is perhaps most significant because it offers the possibility to create a super hybrid by merging it with Dragon Silk and other strains.”

“Even as we ramp up the production of Dragon Silk^TM to fulfil our government contract and supply product for industry, we are inventing the next generation of materials to penetrate new markets,” said Company Founder and CEO Kim Thompson.  “This laboratory breakthrough, so close on the heels of the launching of our production facility, emphasizes our lead in this burgeoning field,” continued Thompson.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com